Global Viral-Vectored Vaccines Market Research Report Forecast 2017-2021

Chapter 1 Viral-Vectored Vaccines Market Overview

1.1 Product Overview and Scope of Viral-Vectored Vaccines

1.2 Viral-Vectored Vaccines Market Segmentation by Type

1.2.1 Global Production Market Share of Viral-Vectored Vaccines by Type in 2015

1.2.1 Type 1

1.2.2 Type 2

1.2.3 Type 3

1.3 Viral-Vectored Vaccines Market Segmentation by Application

1.3.1 Viral-Vectored Vaccines Consumption Market Share by Application in 2015

1.3.2 Application 1

1.3.3 Application 2

1.3.4 Application 3

1.4 Viral-Vectored Vaccines Market Segmentation by Regions

1.4.1 North America

1.4.2 China

1.4.3 Europe

1.4.4 Southeast Asia

1.4.5 Japan

1.4.6 India

1.5 Global Market Size (Value) of Viral-Vectored Vaccines (2012-2021)

Chapter 2 Global Economic Impact on Viral-Vectored Vaccines Industry

2.1 Global Macroeconomic Environment Analysis

2.1.1 Global Macroeconomic Analysis

2.1.2 Global Macroeconomic Environment Development Trend

2.2 Global Macroeconomic Environment Analysis by Regions

Chapter 3 Global Viral-Vectored Vaccines Market Competition by Manufacturers

3.1 Global Viral-Vectored Vaccines Production and Share by Manufacturers (2015 and 2016)

3.2 Global Viral-Vectored Vaccines Revenue and Share by Manufacturers (2015 and 2016)

3.3 Global Viral-Vectored Vaccines Average Price by Manufacturers (2015 and 2016)

3.4 Manufacturers Viral-Vectored Vaccines Manufacturing Base Distribution, Production Area and Product Type

3.5 Viral-Vectored Vaccines Market Competitive Situation and Trends

3.5.1 Viral-Vectored Vaccines Market Concentration Rate

3.5.2 Viral-Vectored Vaccines Market Share of Top 3 and Top 5 Manufacturers

3.5.3 Mergers & Acquisitions, Expansion

Chapter 4 Global Viral-Vectored Vaccines Production, Revenue (Value) by Region (2012-2017)

4.1 Global Viral-Vectored Vaccines Production by Region (2012-2017)

4.2 Global Viral-Vectored Vaccines Production Market Share by Region (2012-2017)

4.3 Global Viral-Vectored Vaccines Revenue (Value) and Market Share by Region (2012-2017)

4.4 Global Viral-Vectored Vaccines Production, Revenue, Price and Gross Margin (2012-2017)

4.5 North America Viral-Vectored Vaccines Production, Revenue, Price and Gross Margin (2012-2017)

4.6 Europe Viral-Vectored Vaccines Production, Revenue, Price and Gross Margin (2012-2017)

4.7 China Viral-Vectored Vaccines Production, Revenue, Price and Gross Margin (2012-2017)

4.8 Japan Viral-Vectored Vaccines Production, Revenue, Price and Gross Margin (2012-2017)

4.9 Southeast Asia Viral-Vectored Vaccines Production, Revenue, Price and Gross Margin (2012-2017)

4.10 India Viral-Vectored Vaccines Production, Revenue, Price and Gross Margin (2012-2017)

Chapter 5 Global Viral-Vectored Vaccines Supply (Production), Consumption, Export, Import by Regions (2012-2017)

5.1 Global Viral-Vectored Vaccines Consumption by Regions (2012-2017)

5.2 North America Viral-Vectored Vaccines Production, Consumption, Export, Import by Regions (2012-2017)

5.3 Europe Viral-Vectored Vaccines Production, Consumption, Export, Import by Regions (2012-2017)

5.4 China Viral-Vectored Vaccines Production, Consumption, Export, Import by Regions (2012-2017)

5.5 Japan Viral-Vectored Vaccines Production, Consumption, Export, Import by Regions (2012-2017)

5.6 Southeast Asia Viral-Vectored Vaccines Production, Consumption, Export, Import by Regions (2012-2017)

5.7 India Viral-Vectored Vaccines Production, Consumption, Export, Import by Regions (2012-2017)

Chapter 6 Global Viral-Vectored Vaccines Production, Revenue (Value), Price Trend by Type

6.1 Global Viral-Vectored Vaccines Production and Market Share by Type (2012-2017)

6.2 Global Viral-Vectored Vaccines Revenue and Market Share by Type (2012-2017)

6.3 Global Viral-Vectored Vaccines Price by Type (2012-2017)

6.4 Global Viral-Vectored Vaccines Production Growth by Type (2012-2017)

Chapter 7 Global Viral-Vectored Vaccines Market Analysis by Application

7.1 Global Viral-Vectored Vaccines Consumption and Market Share by Application (2012-2017)

7.2 Global Viral-Vectored Vaccines Consumption Growth Rate by Application (2012-2017)

7.3 Market Drivers and Opportunities

7.3.1 Potential Applications

7.3.2 Emerging Markets/Countries

Chapter 8 Global Viral-Vectored Vaccines Manufacturers Analysis

8.1 Bayer HealthCare AG (Germany)

8.1.1 Company Basic Information, Manufacturing Base and Competitors

8.1.2 Product Type, Application and Specification

8.1.3 Production, Revenue, Price and Gross Margin (2012-2017)

8.1.4 Business Overview

8.2 Biogenesis-Bago (Argentina)

8.2.1 Company Basic Information, Manufacturing Base and Competitors

8.2.2 Product Type, Application and Specification

8.2.3 Production, Revenue, Price and Gross Margin (2012-2017)

8.2.4 Business Overview

8.3 Boehringer Ingelheim GmbH (Germany)

8.3.1 Company Basic Information, Manufacturing Base and Competitors

8.3.2 Product Type, Application and Specification

8.3.3 Production, Revenue, Price and Gross Margin (2012-2017)

8.3.4 Business Overview

8.4 Ceva Sante Animale (France)

8.4.1 Company Basic Information, Manufacturing Base and Competitors

8.4.2 Product Type, Application and Specification

8.4.3 Production, Revenue, Price and Gross Margin (2012-2017)

8.4.4 Business Overview

8.5 Heska Corporation (US)

8.5.1 Company Basic Information, Manufacturing Base and Competitors

8.5.2 Product Type, Application and Specification

8.5.3 Production, Revenue, Price and Gross Margin (2012-2017)

8.5.4 Business Overview

8.6 Indian Immunologicals Ltd (India)

8.6.1 Company Basic Information, Manufacturing Base and Competitors

8.6.2 Product Type, Application and Specification

8.6.3 Production, Revenue, Price and Gross Margin (2012-2017)

8.6.4 Business Overview

8.7 Lohmann Animal Health (US)

8.7.1 Company Basic Information, Manufacturing Base and Competitors

8.7.2 Product Type, Application and Specification

8.7.3 Production, Revenue, Price and Gross Margin (2012-2017)

8.7.4 Business Overview

8.8 Merck Animal Health (US)

8.8.1 Company Basic Information, Manufacturing Base and Competitors

8.8.2 Product Type, Application and Specification

8.8.3 Production, Revenue, Price and Gross Margin (2012-2017)

8.8.4 Business Overview

8.9 Merial Ltd. (US)

8.9.1 Company Basic Information, Manufacturing Base and Competitors

8.9.2 Product Type, Application and Specification

8.9.3 Production, Revenue, Price and Gross Margin (2012-2017)

8.9.4 Business Overview

…

Chapter 9 Viral-Vectored Vaccines Manufacturing Cost Analysis

9.1 Viral-Vectored Vaccines Key Raw Materials Analysis

9.1.1 Key Raw Materials

9.1.2 Price Trend of Key Raw Materials

9.1.3 Key Suppliers of Raw Materials

9.1.4 Market Concentration Rate of Raw Materials

9.2 Proportion of Manufacturing Cost Structure

9.2.1 Raw Materials

9.2.2 Labor Cost

9.2.3 Manufacturing Expenses

9.3 Manufacturing Process Analysis of Viral-Vectored Vaccines

Chapter 10 Industrial Chain, Sourcing Strategy and Downstream Buyers

10.1 Viral-Vectored Vaccines Industrial Chain Analysis

10.2 Upstream Raw Materials Sourcing

10.3 Raw Materials Sources of Viral-Vectored Vaccines Major Manufacturers in 2015

10.4 Downstream Buyers

Chapter 11 Marketing Strategy Analysis, Distributors/Traders

11.1 Marketing Channel

11.1.1 Direct Marketing

11.1.2 Indirect Marketing

11.1.3 Marketing Channel Development Trend

11.2 Market Positioning

11.2.1 Pricing Strategy

11.2.2 Brand Strategy

11.2.3 Target Client

11.3 Distributors/Traders List

Chapter 12 Market Effect Factors Analysis

12.1 Technology Progress/Risk

12.1.1 Substitutes Threat

12.1.2 Technology Progress in Related Industry

12.2 Consumer Needs/Customer Preference Change

12.3 Economic/Political Environmental Change

Chapter 13 Global Viral-Vectored Vaccines Market Forecast (2017-2021)

13.1 Global Viral-Vectored Vaccines Production, Revenue Forecast (2017-2021)

13.2 Global Viral-Vectored Vaccines Production, Consumption Forecast by Regions (2017-2021)

13.3 Global Viral-Vectored Vaccines Production Forecast by Type (2017-2021)

13.4 Global Viral-Vectored Vaccines Consumption Forecast by Application (2017-2021)

13.5 Viral-Vectored Vaccines Price Forecast (2017-2021)

Chapter 14 Appendix

Figure Global Production Market Share of Viral-Vectored Vaccines by Type in 2015

Figure Product Picture of Type I

Table Major Manufacturers of Type I

Figure Product Picture of Type II

Table Major Manufacturers of Type II

Figure Product Picture of Type III

Table Major Manufacturers of Type III

Table Viral-Vectored Vaccines Consumption Market Share by Application in 2015

Figure Application 1 Examples

Figure Application 2 Examples

Figure Application 3 Examples

Figure North America Viral-Vectored Vaccines Revenue (Million USD) and Growth Rate (2012-2021)

Figure Europe Viral-Vectored Vaccines Revenue (Million USD) and Growth Rate (2012-2021)

Figure China Viral-Vectored Vaccines Revenue (Million USD) and Growth Rate (2012-2021)

Figure Japan Viral-Vectored Vaccines Revenue (Million USD) and Growth Rate (2012-2021)

Figure Southeast Asia Viral-Vectored Vaccines Revenue (Million USD) and Growth Rate (2012-2021)

Figure India Viral-Vectored Vaccines Revenue (Million USD) and Growth Rate (2012-2021)

Figure Global Viral-Vectored Vaccines Revenue (Million UDS) and Growth Rate (2012-2021)

Table Global Viral-Vectored Vaccines Capacity of Key Manufacturers (2015 and 2016)

Table Global Viral-Vectored Vaccines Capacity Market Share by Manufacturers (2015 and 2016)

Figure Global Viral-Vectored Vaccines Capacity of Key Manufacturers in 2015

Figure Global Viral-Vectored Vaccines Capacity of Key Manufacturers in 2016

Table Global Viral-Vectored Vaccines Production of Key Manufacturers (2015 and 2016)

Table Global Viral-Vectored Vaccines Production Share by Manufacturers (2015 and 2016)

Figure 2015 Viral-Vectored Vaccines Production Share by Manufacturers

Figure 2016 Viral-Vectored Vaccines Production Share by Manufacturers

Table Global Viral-Vectored Vaccines Revenue (Million USD) by Manufacturers (2015 and 2016)

Table Global Viral-Vectored Vaccines Revenue Share by Manufacturers (2015 and 2016)

Table 2015 Global Viral-Vectored Vaccines Revenue Share by Manufacturers

Table 2016 Global Viral-Vectored Vaccines Revenue Share by Manufacturers

Table Global Market Viral-Vectored Vaccines Average Price of Key Manufacturers (2015 and 2016)

Figure Global Market Viral-Vectored Vaccines Average Price of Key Manufacturers in 2015

Table Manufacturers Viral-Vectored Vaccines Manufacturing Base Distribution and Sales Area

Table Manufacturers Viral-Vectored Vaccines Product Type

Figure Viral-Vectored Vaccines Market Share of Top 3 Manufacturers

Figure Viral-Vectored Vaccines Market Share of Top 5 Manufacturers

Table Global Viral-Vectored Vaccines Capacity by Regions (2012-2017)

Figure Global Viral-Vectored Vaccines Capacity Market Share by Regions (2012-2017)

Figure Global Viral-Vectored Vaccines Capacity Market Share by Regions (2012-2017)

Figure 2015 Global Viral-Vectored Vaccines Capacity Market Share by Regions

Table Global Viral-Vectored Vaccines Production by Regions (2012-2017)

Figure Global Viral-Vectored Vaccines Production and Market Share by Regions (2012-2017)

Figure Global Viral-Vectored Vaccines Production Market Share by Regions (2012-2017)

Figure 2015 Global Viral-Vectored Vaccines Production Market Share by Regions

Table Global Viral-Vectored Vaccines Revenue by Regions (2012-2017)

Table Global Viral-Vectored Vaccines Revenue Market Share by Regions (2012-2017)

Table 2015 Global Viral-Vectored Vaccines Revenue Market Share by Regions

Table Global Viral-Vectored Vaccines Production, Revenue, Price and Gross Margin (2012-2017)

Table North America Viral-Vectored Vaccines Production, Revenue, Price and Gross Margin (2012-2017)

Table Europe Viral-Vectored Vaccines Production, Revenue, Price and Gross Margin (2012-2017)

Table China Viral-Vectored Vaccines Production, Revenue, Price and Gross Margin (2012-2017)

Table Japan Viral-Vectored Vaccines Production, Revenue, Price and Gross Margin (2012-2017)

Table Southeast Asia Viral-Vectored Vaccines Production, Revenue, Price and Gross Margin (2012-2017)

Table India Viral-Vectored Vaccines Production, Revenue, Price and Gross Margin (2012-2017)

Table Global Viral-Vectored Vaccines Consumption Market by Regions (2012-2017)

Table Global Viral-Vectored Vaccines Consumption Market Share by Regions (2012-2017)

Figure Global Viral-Vectored Vaccines Consumption Market Share by Regions (2012-2017)

Figure 2015 Global Viral-Vectored Vaccines Consumption Market Share by Regions

Table North America Viral-Vectored Vaccines Production, Consumption, Import & Export (2012-2017)

Table Europe Viral-Vectored Vaccines Production, Consumption, Import & Export (2012-2017)

Table China Viral-Vectored Vaccines Production, Consumption, Import & Export (2012-2017)

Table Japan Viral-Vectored Vaccines Production, Consumption, Import & Export (2012-2017)

Table Southeast Asia Viral-Vectored Vaccines Production, Consumption, Import & Export (2012-2017)

Table India Viral-Vectored Vaccines Production, Consumption, Import & Export (2012-2017)

Table Global Viral-Vectored Vaccines Production by Type (2012-2017)

Table Global Viral-Vectored Vaccines Production Share by Type (2012-2017)

Figure Production Market Share of Viral-Vectored Vaccines by Type (2012-2017)

Figure 2015 Production Market Share of Viral-Vectored Vaccines by Type

Table Global Viral-Vectored Vaccines Revenue by Type (2012-2017)

Table Global Viral-Vectored Vaccines Revenue Share by Type (2012-2017)

Figure Production Revenue Share of Viral-Vectored Vaccines by Type (2012-2017)

Figure 2015 Revenue Market Share of Viral-Vectored Vaccines by Type

Table Global Viral-Vectored Vaccines Price by Type (2012-2017)

Figure Global Viral-Vectored Vaccines Production Growth by Type (2012-2017)

Table Global Viral-Vectored Vaccines Consumption by Application (2012-2017)

Table Global Viral-Vectored Vaccines Consumption Market Share by Application (2012-2017)

Figure Global Viral-Vectored Vaccines Consumption Market Share by Application in 2015

Table Global Viral-Vectored Vaccines Consumption Growth Rate by Application (2012-2017)

Figure Global Viral-Vectored Vaccines Consumption Growth Rate by Application (2012-2017)

Table Bayer HealthCare AG (Germany) Basic Information, Manufacturing Base, Production Area and Its Competitors

Table Bayer HealthCare AG (Germany) Viral-Vectored Vaccines Production, Revenue, Price and Gross Margin (2012-2017)

Table Bayer HealthCare AG (Germany) Viral-Vectored Vaccines Market Share (2012-2017)

Table Biogenesis-Bago (Argentina) Basic Information, Manufacturing Base, Production Area and Its Competitors

Table Biogenesis-Bago (Argentina) Viral-Vectored Vaccines Production, Revenue, Price and Gross Margin (2012-2017)

Table Biogenesis-Bago (Argentina) Viral-Vectored Vaccines Market Share (2012-2017)

Table Boehringer Ingelheim GmbH (Germany) Basic Information, Manufacturing Base, Production Area and Its Competitors

Table Boehringer Ingelheim GmbH (Germany) Viral-Vectored Vaccines Production, Revenue, Price and Gross Margin (2012-2017)

Table Boehringer Ingelheim GmbH (Germany) Viral-Vectored Vaccines Market Share (2012-2017)

Table Ceva Sante Animale (France) Basic Information, Manufacturing Base, Production Area and Its Competitors

Table Ceva Sante Animale (France) Viral-Vectored Vaccines Production, Revenue, Price and Gross Margin (2012-2017)

Table Ceva Sante Animale (France) Viral-Vectored Vaccines Market Share (2012-2017)

Table Heska Corporation (US) Basic Information, Manufacturing Base, Production Area and Its Competitors

Table Heska Corporation (US) Viral-Vectored Vaccines Production, Revenue, Price and Gross Margin (2012-2017)

Table Heska Corporation (US) Viral-Vectored Vaccines Market Share (2012-2017)

Table Indian Immunologicals Ltd (India) Basic Information, Manufacturing Base, Production Area and Its Competitors

Table Indian Immunologicals Ltd (India) Viral-Vectored Vaccines Production, Revenue, Price and Gross Margin (2012-2017)

Table Indian Immunologicals Ltd (India) Viral-Vectored Vaccines Market Share (2012-2017)

Table Lohmann Animal Health (US) Basic Information, Manufacturing Base, Production Area and Its Competitors

Table Lohmann Animal Health (US) Viral-Vectored Vaccines Production, Revenue, Price and Gross Margin (2012-2017)

Table Lohmann Animal Health (US) Viral-Vectored Vaccines Market Share (2012-2017)

Table Merck Animal Health (US) Basic Information, Manufacturing Base, Production Area and Its Competitors

Table Merck Animal Health (US) Viral-Vectored Vaccines Production, Revenue, Price and Gross Margin (2012-2017)

Table Merck Animal Health (US) Viral-Vectored Vaccines Market Share (2012-2017)

Table Merial Ltd. (US) Basic Information, Manufacturing Base, Production Area and Its Competitors

Table Merial Ltd. (US) Viral-Vectored Vaccines Production, Revenue, Price and Gross Margin (2012-2017)

Table Merial Ltd. (US) Viral-Vectored Vaccines Market Share (2012-2017)

…

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Viral-Vectored Vaccines

Figure Manufacturing Process Analysis of Viral-Vectored Vaccines

Figure Viral-Vectored Vaccines Industrial Chain Analysis

Table Raw Materials Sources of Viral-Vectored Vaccines Major Manufacturers in 2015

Table Major Buyers of Viral-Vectored Vaccines

Table Distributors/Traders List

Figure Global Viral-Vectored Vaccines Production and Growth Rate Forecast (2017-2021)

Figure Global Viral-Vectored Vaccines Revenue and Growth Rate Forecast (2017-2021)

Table Global Viral-Vectored Vaccines Production Forecast by Regions (2017-2021)

Table Global Viral-Vectored Vaccines Consumption Forecast by Regions (2017-2021)

Table Global Viral-Vectored Vaccines Production Forecast by Type (2017-2021)

Table Global Viral-Vectored Vaccines Consumption Forecast by Application (2017-2021)